Raymond James & Associates’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$1.69M Buy
227,953
+45,010
+25% +$333K ﹤0.01% 2322
2024
Q2
$1.47M Buy
182,943
+47,670
+35% +$382K ﹤0.01% 2338
2024
Q1
$1.57M Buy
135,273
+26,870
+25% +$313K ﹤0.01% 2303
2023
Q4
$1.21M Buy
108,403
+5,415
+5% +$60.5K ﹤0.01% 2401
2023
Q3
$1.59M Buy
102,988
+3,464
+3% +$53.5K ﹤0.01% 2146
2023
Q2
$1.89M Buy
99,524
+29,421
+42% +$558K ﹤0.01% 2082
2023
Q1
$1.07M Buy
70,103
+30,150
+75% +$459K ﹤0.01% 2405
2022
Q4
$509K Sell
39,953
-554
-1% -$7.05K ﹤0.01% 2879
2022
Q3
$235K Buy
40,507
+21,000
+108% +$122K ﹤0.01% 3323
2022
Q2
$63K Buy
+19,507
New +$63K ﹤0.01% 3707
2021
Q2
Sell
-22,985
Closed -$544K 3926
2021
Q1
$544K Buy
+22,985
New +$544K ﹤0.01% 2942